Transposable elements, also known as transposons, are now recognized not only as parasitic DNA, the spread of which in the genome must be controlled by the host, but also as major players in genome evolution and regulation 1-6 . Long interspersed element-1 (LINE-1, also known as L1), the only currently autonomous mobile transposon in humans, occupies 17% of the genome and generates inter-and intra-individual genetic variation, in some cases resulting in disease 1-7 . However, how L1 activity is controlled and the function of L1s in host gene regulation are not completely understood. Here we use CRISPR-Cas9 screening strategies in two distinct human cell lines to provide a genome-wide survey of genes involved in the control of L1 retrotransposition. We identify functionally diverse genes that either promote or restrict L1 retrotransposition. These genes, which are often associated with human diseases, control the L1 life cycle at the transcriptional or the post-transcriptional level in a manner that can depend on the endogenous L1 nucleotide sequence, underscoring the complexity of L1 regulation. We further investigate the restriction of L1 by the protein MORC2 and by the human silencing hub (HUSH) complex subunits MPP8 and TASOR 8 . HUSH and MORC2 can selectively bind evolutionarily young, full-length L1s located within transcriptionally permissive euchromatic environments, and promote deposition of histone H3 Lys9 trimethylation (H3K9me3) for transcriptional silencing. Notably, these silencing events often occur within introns of transcriptionally active genes, and lead to the downregulation of host gene expression in a HUSH-, MORC2-, and L1-dependent manner. Together, these results provide a rich resource for studies of L1 retrotransposition, elucidate a novel L1 restriction pathway and illustrate how epigenetic silencing of transposable elements rewires host gene expression programs.
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Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators
Nian Liu 1 *, Cameron H. Lee 2 *, Tomek Swigut 1 , Edward Grow 2 †, Bo Gu 1 , Michael C. Bassik 2, 3 & joanna Wysocka 1, 4, 5, 6 Transposable elements, also known as transposons, are now recognized not only as parasitic DNA, the spread of which in the genome must be controlled by the host, but also as major players in genome evolution and regulation 1-6 . Long interspersed element-1 (LINE-1, also known as L1), the only currently autonomous mobile transposon in humans, occupies 17% of the genome and generates inter-and intra-individual genetic variation, in some cases resulting in disease [1] [2] [3] [4] [5] [6] [7] . However, how L1 activity is controlled and the function of L1s in host gene regulation are not completely understood. Here we use CRISPR-Cas9 screening strategies in two distinct human cell lines to provide a genome-wide survey of genes involved in the control of L1 retrotransposition. We identify functionally diverse genes that either promote or restrict L1 retrotransposition. These genes, which are often associated with human diseases, control the L1 life cycle at the transcriptional or the post-transcriptional level in a manner that can depend on the endogenous L1 nucleotide sequence, underscoring the complexity of L1 regulation. We further investigate the restriction of L1 by the protein MORC2 and by the human silencing hub (HUSH) complex subunits MPP8 and TASOR 8 . HUSH and MORC2 can selectively bind evolutionarily young, full-length L1s located within transcriptionally permissive euchromatic environments, and promote deposition of histone H3 Lys9 trimethylation (H3K9me3) for transcriptional silencing. Notably, these silencing events often occur within introns of transcriptionally active genes, and lead to the downregulation of host gene expression in a HUSH-, MORC2-, and L1-dependent manner. Together, these results provide a rich resource for studies of L1 retrotransposition, elucidate a novel L1 restriction pathway and illustrate how epigenetic silencing of transposable elements rewires host gene expression programs.
Most of our knowledge about the control of L1 retrotransposition comes from studies examining individual candidate genes [2] [3] [4] [5] [6] . To systematically identify genes regulating L1 retrotransposition, we performed a genome-wide CRISPR-Cas9 screen in human chronic myeloid leukaemia K562 cells using an L1-G418 R retrotransposition reporter 9 (in which G418 R indicates resistance to the antibiotic G418, also known as geneticin) ( Fig. 1a, b) . The L1-G418 R reporter was modified to be driven by a doxycycline (dox)-responsive promoter, rather than the native L1 5′ untranslated region (5′ UTR), to avoid leaky retrotransposition before the functional screen (Extended Data Fig. 1a-c) . The cells become G418 R antibiotic-resistant only when the L1-G418 R reporter undergoes a successful retrotransposition event after dox induction (Fig. 1b ). For the screen, we transduced clonal L1-G418 R cells with a lentiviral genome-wide single-guide RNA (sgRNA) library such that each cell expressed a single sgRNA 10 . We then treated the cells with dox to activate the L1-G418 R reporter for retrotransposition, and split the cells into G418-selected conditions and unselected conditions, which served to eliminate cell growth bias in the screen analysis. The frequencies of sgRNAs in the two populations were measured by deep sequencing (Fig. 1a ) and analysed using Cas9 high-throughput maximum likelihood estimator (CasTLE) 11 . Consequently, cells transduced with sgRNAs targeting L1 suppressors would have more retrotransposition events than negative control cells and would be enriched through the G418 selection; conversely, cells transduced with sgRNAs targeting L1 activators would be depleted.
Using this strategy, we identified 25 putative L1 regulators at a 10% false discovery rate (FDR) cutoff, and 150 genes at a 30% FDR cutoff ( Fig. 1c and Extended Data Fig. 1d ; see Supplementary Table 1 for the full list). Despite low statistical confidence, many of the 30%-FDRcutoff genes overlapped previously characterized L1 regulators (for example, ALKBH1 and SETDB1) and genes functioning in complexes with our top 10% FDR hits (for example, the Fanconi anaemia pathway and the HUSH complex), suggesting that they probably encompassed biologically relevant hits. To increase statistical power in distinguishing bona fide L1 regulators among these, we performed a high-coverage secondary screen targeting the 30% FDR hits (150 genes) and an additional 100 genes that were either functionally related to our top hits or were otherwise previously known to regulate L1 but fell outside of the 30%-FDR-cutoff threshold (see Supplementary Table 2 for the full list). This secondary screen validated 90 genes out of the top 150 genomewide screen hits, a fraction close to that expected with the 30% FDR cutoff ( Fig. 1d and Extended Data Fig. 2a-c) .
Our two-tier screening approach identified 142 human genes that either activate or repress L1 retrotransposition in K562 cells, encompassing over 20 previously known L1 regulators (Extended Data Fig. 2d ). Novel candidates are involved in functionally diverse pathways, including those of chromatin regulation, DNA damage and repair, and RNA processing (Extended Data Fig. 2e , f). Whereas many DNA damage or repair factors-particularly the Fanconi anaemia factors-suppress the activity of L1, genes implicated in the non-homologous end joining repair pathway promote L1 retrotransposition (Extended Data Fig. 2f ). In agreement with this, mutations in some of the factors identified in this pathway were previously found to result in decreased retrotransposition frequencies 12 . Notably, many hits uncovered by our screen (for example, Fanconi anaemia factors, MORC2 and SETX) are associated with human disorders [13] [14] [15] [16] [17] .
To extend our survey of L1 regulators to another cell type, we performed both a genome-wide and a secondary screen in HeLa cells (Extended Data Fig. 1b, e ) with the same sgRNA libraries used in the effects of the Fanconi anaemia complex genes, and the activating effects of the non-homologous end joining pathway genes (Extended Data Fig. 3b-e ). Of note, however, is that a subset of genes showed cell-line-selective effects (Extended Data Fig. 3c ). At the same time, some of the previously known L1 regulators did not appear as hits in our screen. Several factors could limit our ability to identify all the genes controlling L1 retrotransposition to saturation. For example, a subset of regulators may function in a cell-type specific manner that is not captured by either K562 or HeLa screens; essential genes with strong negative effects on cell growth may have dropped out; or regulators that strictly require native L1 UTR sequences may have been missed owing to our reporter design. However, our combined screens identify many novel candidates for the control of L1 retrotransposition in human cells and provide a rich resource for mechanistic studies of transposable elements.
Select screen hits were further validated in K562 cells using a well-characterized L1-GFP reporter 18 (Extended Data Fig. 1a ), confirming 13 suppressors and 1 activator (SLTM) out of 16 examined genes ( Fig. 1e ). Notably, chromatin regulators (TASOR, MORC2, MPP8, SAFB and SETDB1) suppress the retrotransposition of the L1-GFP reporter, but not that of a previously described codon-optimized L1-GFP reporter (hereafter referred to as (opt)-L1-GFP) 19, 20 , indicating that these factors regulate L1 retrotransposition in a manner dependent upon the open reading frame (ORF) nucleotide sequence of the native L1 (Extended Data Fig. 3f, g) . An additional secondary screen against the codon-optimized (opt)-L1-G418 R reporter in K562 cells confirmed the sequence-dependent nature of these L1 regulators, and systematically partitioned our top screen hits into native L1 sequence-dependent and -independent candidates (Extended Data Fig. 3h ; see Supplementary Table 2 for the full list).
We next examined whether the identified regulators influence the expression of endogenous L1Hs, the youngest and only retrotransposition-competent L1 subfamily in humans. CRISPRdeletion of some genes (TASOR, MPP8 (also known as MPHOSPH8), SAFB and MORC2) significantly increased the expression of endogenous L1Hs, whereas deletion of other genes-such as SETX, RAD51 or Fanconi anaemia complex components-had little effect ( Fig. 1f ). Because all of the genes we studied restrict L1-GFP retrotransposition into the genome ( Fig. 1e and Extended Data Fig. 4a ), our results suggest that the identified suppressors can function at either the transcriptional or the post-transcriptional level.
We further investigated three candidate transcriptional regulators of L1: MORC2, TASOR and MPP8. TASOR and MPP8 (along with PPHLN1) comprise the HUSH complex, and recruit the H3K9me3 methyltransferase SETDB1 to repress genes 8 . Notably, PPHLN1 and SETDB1 were also identified as L1 suppressors in our screen ( Fig. 1d and Extended Data Fig. 3b ). MORC2, which has recently been shown to biochemically and functionally interact with HUSH 21 , is a member of the microrchidia (MORC) protein family that has been implicated in transposon silencing in plants and mice 22, 23 . Although MORC2 and HUSH have been previously implicated in heterochromatin formation, most heterochromatin factors had no effect on L1 retrotransposition, suggesting a selective effect ( Fig. 2a and Extended Data Fig. 4b ).
Several independent experiments in clonal knockout K562 lines confirmed that HUSH and MORC2 suppress the retrotransposition of the L1-GFP reporter by silencing its transcription (Fig. 2b, c 
LGR6 HTR1F
CBX3 CHST14 AQR Secondary screen with L1-G418 R in K562 cells Relative GFP + fraction ** *** ** *** Figure 1 | Genome-wide screen for L1 activators and suppressors in K562 cells. a, Schematic of the screening process. b, Schematic of the L1-G418 R retrotransposition. c, CasTLE analysis of two independent K562 genome-wide screens. Genes at 10% FDR cutoff coloured in blue, analysed by CasTLE likelihood ratio test 11 . d, The maximum effect size (centre value) estimated by CasTLE from two independent K562 secondary screens with ten independent sgRNAs per gene. Bars, 95% credible interval. L1 activators are shown in red; L1 suppressors are shown in blue; and insignificant genes for which the credible interval includes zero are shown in grey. e, L1-GFP retrotransposition in control (infected with negative control sgRNAs, hereafter referred to as 'control') and mutant K562 cells as indicated. GFP + cell fractions are normalized to the control, the centre value is the median. n = 3 biological replicates per gene. f, RT-qPCR measuring the expression of endogenous L1Hs in mutant K562 cells, normalized to control. The centre value is the median. n = 3 technical replicates per gene. * * P < 0.01; * * * P < 0.001; two-sided Welch t-test.
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Extended Data Fig. 4c-f ). Additionally, HUSH and MORC2 repressed endogenous (non-reporter) L1Hs RNA and protein expression in both K562 and human embryonic stem cells 24 (hES cells, H9) ( Fig. 2d and Extended Data Fig. 4g -k). PolyA-selected RNA sequencing (RNA-seq) experiments revealed the upregulated expression of evolutionarily younger L1PA families (including L1Hs) upon HUSH or MORC2 knockout in K562 cells ( Fig. 2e ). Taken together, these data demonstrate that HUSH and MORC2 silence both the reporter transgene as well as endogenous, evolutionarily young L1s.
Chromatin immunoprecipitation followed by sequencing (ChIPseq) from K562 cells and hES cells demonstrated that MORC2, MPP8 and TASOR co-bind genomic regions characterized by specific L1 instances. Elements from the primate-specific L1P family showed greater enrichment than elements from the older L1M family (Fig. 3a, b and Extended Data Figs 5a, b, 6a, b), consistent with the preferential derepression of the former upon HUSH or MORC2 knockout ( Fig. 2e ).
Moreover, this enrichment was specific to L1s, as other major repeat classes were not enriched ( Fig. 3b and Extended Data Fig. 6b ), although all three proteins also targeted the expressed KRAB zinc-finger (KRAB-ZNF) genes (Extended Data Fig. 5c, d ). HUSH knockout in K562 cells almost completely abrogated MORC2 binding at L1s (consistent with recently published observations that HUSH recruits MORC2 for transcriptional repression 21 ), whereas MORC2 deletion led to a modest but appreciable decrease of HUSH subunit binding (Extended Data Fig. 7 ). In mouse ES cells, MPP8 was found to bind retrotranspositioncompetent L1Md-A and L1Md-T, as well as IAP elements, which are a class of murine endogenous retroviruses that remain currently mobile in the mouse genome (Extended Data Fig. 6c, d ). This suggests that regulators uncovered by our study in human cells may, in other species, target additional active transposons beyond L1s.
Notably, only a subset of L1Ps is bound by HUSH or MORC2 in either K562 cells or hESCs; this is seen even for the younger human L1Ps. We sought to identify genomic or epigenomic features that could explain this selectivity. We found that HUSH and MORC2 selectively Knockout2 target young, full-length L1s, particularly the L1PA1-5 in human cells ( Fig. 3c, d ) and the L1Md-A/T in mice (Extended Data Fig. 6e ). Both MPP8 and MORC2 bind broadly across the L1; whereas MORC2 binding is skewed towards the 5′ end, MPP8 shows higher enrichments within the body and at the 3′ end of L1PAs, including the L1Hs (L1PA1) elements (Extended Data Fig. 6f , g). However, the preference for full-length, evolutionarily younger L1PAs can only partially explain the observed selectivity of HUSH and MORC2, as only a subset of such elements are targeted by the complex (Fig. 3d ). We found that the additional layer of selectivity can be explained by the state of the surrounding chromatin, with HUSH-or MORC2-occupied L1s preferentially located within the transcriptionally permissive euchromatic environment marked by modifications such as H3K4me3 (histone H3 Lys4 trimethylation) and H3K27ac (histone H3 Lys27 acetylation) ( Fig. 3e ). In agreement with this, HUSH-or MORC2-bound L1s are enriched within introns of actively transcribed genes (Extended Data Fig. 8a, b ). Furthermore, although most HUSH-or MORC2-bound L1s are concordant between K562 and hES cells, those that are bound in a cell-type-specific manner tend to be associated with genes that are differentially active between the two cell types (Extended Data Fig. 8c ). To understand the role of transcription in the HUSH and MORC2 targeting of L1s, we investigated MORC2 and MPP8 occupancy at the inducible L1 transgene. We observed increased binding of these factors upon transcriptional induction (Extended Data Fig. 8d ), suggesting that transcription through L1 sequences facilitates HUSH and MORC2 binding. Together, HUSH and MORC2 selectively target young, full-length L1s located within transcriptionally permissive euchromatic regions. These L1s are precisely the elements that pose the highest threat to genome integrity, as a subset of them remains mobile and transcription is the first step of L1 mobilization.
Despite their location within the euchromatic environment, HUSHand MORC2-bound L1s themselves are heavily modified with the transcriptionally repressive H3K9me3 (Fig. 3e ), consistent with the role of HUSH in facilitating H3K9me3 deposition at target sites 8 . HUSH or MORC2 knockout decreased H3K9me3 levels preferentially at L1 rather than at non-L1 HUSH or MORC2 genomic targets, and at bound versus unbound L1s ( Fig. 4a and Extended Data Fig. 9a, b ). Because HUSH-and MORC2-bound L1s are significantly enriched within introns of transcriptionally active genes (Extended Data Fig. 8a -c), we examined whether HUSH or MORC2 recruitment and its associated H3K9me3 deposition can influence chromatin modification and expression of the host genes. Despite a transcriptionally active status (Extended Data Fig. 8a, b ), promoters and especially bodies of genes harbouring MORC2-or HUSH-bound L1s show appreciable levels of H3K9me3. This enrichment is substantially diminished in the knockout lines (Extended Data Fig. 9c ), with concomitant upregulation of genes that harbour MORC2-or HUSH-bound L1s, but not of those with unbound intronic L1s (Fig. 4b ). Thus, HUSH or MORC2 binding at intronic L1s leads to a modest but significant downregulation of the active genes that harbour them ( Fig. 4c and Extended Data Figs 9d-g, 10a).
Inserting L1 sequences in a transcript leads to a decrease in RNA expression due to inadequate transcript elongation 25 , and this effect has been attributed to the A/T enrichment of L1s. However, our results argue that the transcriptional attenuation of host gene expression could be a consequence of epigenetic silencing by HUSH or MORC2 (Fig. 4b, c and Extended Data Figs 9d-g, 10a), and this possibility is consistent with the described role of genic H3K9me3 in decreasing the Pol II elongation rate, leading to its accumulation over the H3K9me3 region 26 . If such a mechanism is involved, then HUSH knockout should decrease accumulation of the elongating Pol II over L1 bodies, and this is indeed what we observe in Pol II ChIP-seq experiments (although notably, at the 5′ UTRs of L1s, Pol II levels are relatively increased in the knockouts) (Extended Data Fig. 10b ).
Host gene regulation is directly dependent on the presence of the intronic L1, as deletion of select MORC2-or HUSH-bound L1s from the intron leads to the upregulation of host mRNA to a level commensurate with the magnitude of changes caused by HUSH or MORC2 knockout ( Fig. 4d , e and Extended Data Fig. 10c, d ). Thus, attenuated expression level of an active gene can be a by-product of a retrotransposition event and associated HUSH-and MORC2-mediated L1 silencing ( Fig. 4f ). Although the observed effects on active host genes are only modulatory, they occur to various extents at hundreds of human genes, illustrating how transposable element activity can rewire host gene expression patterns.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Loss of HUSH or MORC2 causes a decrease of H3K9me3 at the target L1 and an increase in expression of both the target L1 and its host gene, independently repeated once with similar results. KO, knockout. d, Deleting the target intronic L1 from CYP3A5 in K562 increases CYP3A5 expression, as measured by RT-qPCR normalized to a wild-type sample. n = 2 biological replicates × 3 technical replicates; centre value is median. The gel confirms L1 deletion; two experiments repeated independently with similar results. e, RT-qPCR for CYP3A5 expression in K562 clones, normalized to the control. n = 2 biological replicates × 3 technical replicates; centre value is median. KO, knockout. f, HUSH and MORC2 bind young full-length L1s within transcriptionally active genes, and promote H3K9me3 deposition at target L1s to silence L1 transcription. This pathway not only inhibits L1 retrotransposition, but also decreases host gene expression.
MethODS Data reporting. No statistical methods were used to predetermine sample size. The experiments were not randomized, and the investigators were not blinded to allocation during experiments and outcome assessment. Cell culture and antibodies. K562 cells (American Type Culture Collection, ATCC) were grown in Roswell Park Memorial Institute (RPMI) 1640 Medium (11875093, Life Technologies) supplemented with 10% fetal bovine serum (Fisher, SH30910), 2 mM l-glutamine (Fisher, SH3003401) and 1% penicillin-streptomycin (Fisher, SV30010), and cultured at 37 °C with 5% CO 2 . HeLa cells (ATCC) were grown in Dulbecco's modified Eagle's medium (Life Technologies, 11995073) supplemented with 10% FBS, 2 mM l-glutamine, and 1% penicillin-streptomycin, and cultured at 37 °C with 5% CO 2 . H9 human ES cells (WiCell) were expanded in feeder-free, serum-free medium mTeSR-1 from StemCell technologies, passaged 1:6 every 5-6 days using accutase (Invitrogen) and replated on tissue culture dishes coated overnight with growth-factor-reduced Matrigel (BD Biosciences). Male mouse embryonic stem cells (ES-E14TG2a, ATCC) were grown as described 28 . Cell lines were authenticated by the vendor. Cell cultures were routinely tested and found to be negative for mycoplasma infection (MycoAlert, Lonza). Rabbit MORC2 antibody (A300-149A, Bethyl Laboratories), Rabbit MPP8 antibody (16796-1-AP, Protein Technologies Inc.), Rabbit TASOR antibody (HPA006735, Atlas Antibodies) were used in western blots (1:1,000 dilution) and ChIP assays. Mouse anti-LINE-1 ORF1p antibody (MABC1152, Millipore) 29 , Rabbit HSP90 (C45G5, Cell Signalling, 4877) and β -actin antibody (ab49900, Abcam) were used in western blots. Histone H3 (tri-methyl K9) antibody (ab8898, Abcam) and RNA Pol II (Santa Cruz Biotechnology, N-20 sc-899) were used in ChIP assays. L1 reporters. The L1-ORF1-ORF2 sequence is derived from the LRE-GFP 30 , a gift from J. Moran. To make the L1-GFP reporter, we used Gibson assembly to clone the L1_ORF1/2 fragment and a GFP-β -globin-intron cassette driven by the mammalian promoter EF1a into the pB transgene using a dox-inducible promoter (modified from PBQM812A-1, System Biosciences) to drive the L1 sequence and a UBC-RTTA3-ires Blast as a selectable marker for reporter integration. To make the L1-G418 R reporter, we replaced the GFP-β -globin-intron fragment in the L1-GFP reporter with a NEO-intron-NEO cassette driven by the mammalian promoter EF1a. The codon-optimized L1-ORF1-ORF2 sequence in our (opt)-L1 reporter is derived from the SynL1_optORF1_neo, a gift from A. Engel 31 . We replaced the self-splicing Tetrahymena NEO-intron-NEO cassette with the neo-β -globinintron-neo cassette driven by the EF1a promoter or the GFP-β -globin-intron-GFP cassette driven by the EF1a promoter. This L1-syn-ORF1-ORF2-indicator cassette was inserted into the pB transgene using a dox-inducible promoter and a UBC-RTTA3-ires Blast, as described previously. Genome-wide screen in K562 cells. The K562 cell line (with a BFP-Cas9 lentiviral transgene) was nucleofected with the pB-tetO-L1-G418 R /Blast construct and the piggyBac transposase (PB210PA-1, System Biosciences) following the manufacturer's instructions (Lonza 2b nucleofector, T-016 program). The nucleofected cells were sorted using limiting dilution in 96-well plates, and positive clones were screened first for sensitivity to Blast, and then the ability to generate G418-resistant cells after dox induction. The Cas9/L1-G418 R cells were lentivirally infected with a genome-wide sgRNA library as described previously 10 , containing approximately 200,000 sgRNAs targeting 20,549 protein-coding genes and 13,500 negative-control sgRNAs at a multiplicity of infection of 0.3-0.4 (as measured by the mCherry fluorescence from the lentiviral vector), and selected for lentiviral integration using puromycin (1 μ g ml −1 ) for 3 days as the cultures were expanded for the screens. In duplicate, 200 × 10 6 library-infected cells were dox-induced (1 μ g ml −1 ) for 10 consecutive days, with a logarithmic growth (500,000 cells per ml) maintained each day of the dox induction. After dox induction, the cells were recovered in normal RPMI complete medium for 24 h, and then split into the G418-selection condition (300 μ g ml −1 G418, Life Technologies, 11811031) and non-selection conditions. After 7 days of maintaining cells at 500,000 per ml, 200 million cells under each condition were recovered in normal RPMI medium for 24 h, before they were pelleted by centrifugation for genomic DNA extraction using Qiagen DNA Blood Maxi kit (51194) as described 32 . The sgRNA-encoding constructs were PCR-amplified using Agilent Herculase II Fusion DNA Polymerase (600675) (see Supplementary Table 4 for the primer sequences used). These libraries were then sequenced across two Illumina NextSeq flow cells (approximately 40 million reads per condition; around 200× coverage per library element). Computational analysis of genome-wide screen was performed as previously described 10, 11 using CasTLE, which is a maximum likelihood estimator that uses a background of negative control sgRNAs as a null model to estimate gene effect sizes. See Supplementary Table  1 for the K562 genome-wide screen results. Secondary screen in K562 cells. The secondary screen library included the following, non-comprehensive sets of genes (253 genes in total, around 10 sgRNAs per gene, plus 2,500 negative control sgRNAs): all genes falling within approximately 30% FDR from the K562 genome-wide screen (around 150 genes); genes known to be functionally related to the 30% FDR genes, genes previously implicated in L1 biology; and genes involved in epigenetic regulation or position effect variegation (see Supplementary Table 2 for a complete list). The library oligonucleotides were synthesized by Agilent Technologies and cloned into pMCB320 using BstXI/BlpI overhangs after PCR amplification. The Cas9/ L1-G418 R (or Cas9/(opt)-L1-G418 R ) K562 cell line was lentivirally infected with the secondary library (around 4,500 elements) at an multiplicity of infection of 0.3-0.4 as described previously 33 . After puromycin selection (1 μ g ml −1 for 3 days) and expansion, 40 million (approximately 9,000 coverage per library element) cells were dox-induced for 10 days in replicate, recovered for 1 day, and split for 7-day G418-selection and non-selection conditions, with a logarithmic growth (500,000 cells per ml) maintained as in the K562 genome-wide screen. 10 million cells under each condition were used for genomic extractions, sequenced (approximately 6-10 million reads per condition; around 1,000-2,000× coverage per library element) and analysed using CasTLE as described above 10, 11 . Supplementary Table  2 lists the K562 secondary screen results with L1-G418 R and (opt)-L1-G418 R . Genome-wide screen and secondary screen in HeLa cells. The pB-tetO-L1-G418 R /Blast construct was integrated into Cas9 expressing HeLa cells with piggyBac transposase via nucleofection (Lonza 2b nucleofector, I-013 program) following the manufacturer's instructions. The Cas9/L1-G418 R HeLa cells were blasticidin (10 μ g ml −1 )-selected, screened for sensitivity to G418 and the ability to generate G418 resistance cells after dox induction, and lentivirally infected with the genome-wide sgRNA library or with the secondary sgRNA library. Infected cells were then puromycin selected (1 μ g ml −1 ) for 5 days and expanded for the screens.
For the genome-wide screen, approximately 200 × 10 6 Cas9/L1-G418 R HeLa cells (around 1,000× coverage of the sgRNA library) were dox-induced for 10 days in replicate, recovered for 1 day, and split for 8-day G418-selection and non-selection conditions, with cells being split every other day to maintain the sgRNA library at a minimum of around 350× coverage. Approximately 200 million (1,000× coverage) cells per condition were used for genomic extractions and sequencing as described above for the K562 screens. Supplementary Table 1 presents the HeLa genome-wide screen results.
For the secondary screen, approximately 1 × 10 7 Cas9/L1-G418 R HeLa cells (around 2,000× coverage of the sgRNA library) were dox-induced for 10 days in replicate, recovered for 1 day, and split for 8-day G418-selection and nonselection conditions, with cells being split every other day to maintain around 400× coverage. Approximately 5 million (1,000× coverage) cells per condition were used for genomic extractions and sequencing as described above. Supplementary Table  2 presents the HeLa secondary screen results.
Validation of individual candidates using the L1-GFP retrotransposition assay.
To validate the genome-wide screen hits, we infected clonal Cas9/L1-GFP K562 cells with individual sgRNAs as previously described 32 , three independent mutant cell lines per gene, each with a different sgRNA (cloned into pMCB320 using BstXI/ BlpI overhangs; mU6:sgRNA; EF1a:puromycin-t2a-mCherry). Supplementary Table 3 lists the sgRNA sequences used. The infected cells were selected against puromycin (1 μ g ml −1 ) for 3 days, recovered in fresh RPMI medium for 1 day, and dox-induced for 10 days. Next, the percentage of GFP + cells was measured on a BD Accuri C6 Flow Cytometer (GFP fluorescence detected in FL1 using 488-nm laser) after gating for live mCherry + cells. CRISPR-mediated deletion of individual genes and intronic L1s. To delete genes in H9 ES cells, we cloned target sgRNAs in pSpCas9(BB)-2A-GFP (PX458) as described 34 . The sgRNA plasmids were prepared with the Nucleospin plasmid kit (Macherey Nagel) and transfected into H9 ES cells using Fugene following the manufacturer's instructions. After 48-72 h, GFP-positive transfected cells were sorted and expanded. Gene depletion effects were validated by western blots.
To delete the L1 from the host gene intron, we designed sgRNAs targeting both upstream and downstream sides of the L1 within the intron; one was cloned into pSpCas9(BB)-2A-BFP, whereas the other was cloned into pSpCas9(BB)-2A-GFP. The two sgRNA plasmids were mixed at a 1:1 ratio and nucleofected into K562 cells via electroporation following the manufacturer's instructions. After 48-72 h, BFP or GFP-positive transfected cells were single-cell sorted and expanded. The genetic deletion effects were validated by PCR assay. Western blotting. Live cells were lysed for 30 min at 4 °C in protein extraction buffer (300 mM NaCl, 100 mM Tris pH 8, 0.2 mM EDTA, 0.1% NP40, 10% glycerol) with protease inhibitors, and centrifuged to collect the supernatant lysate. The cell lysate was measured with Bradford reagent (Biorad), separated on SDS-PAGE gels and transferred to nitrocellulose membranes. The L1-reporter containing K562 cells had not been dox-induced when used for western blot assays characterizing endogenous L1_ORF1p levels ( Fig. 2d and Extended Data Fig. 4k ). PCR and gel electrophoresis. PCR experiments characterizing the L1-G418 R retrotransposition and the deletion of intronic L1s were performed with Phusion High-Fidelity DNA Polymerase (M0530S, New England Biolabs), following the Letter reSeArCH manufacturer's instructions. In general, 30 cycles of PCR reactions were performed at an annealing temperature 5 °C below the melting temperature of the primer. No 'spliced' PCR products were detected without dox induction, even with 40 PCR cycles. PCR reaction products were separated on 1% agarose gels with ethidium bromide. Primer sequences are listed in Supplementary Table 4 . qRT-PCR and PspGI-assisted qPCR. Total RNA was isolated from live cells using the RNeasy kit (74104, Qiagen) and treated with RNase-free DNase Set (79254, Qiagen) to remove genomic DNA, according to the manufacturer's instructions. Total RNA (500 ng) was reverse-transcribed with SuperScriptA III First-Strand Synthesis System (18080051, Life Technologies) following the manufacturer's instructions. β -actin mRNA was used as an internal control within each RNA sample (Figs 1f and 4d, e ). The sequences of PCR primers, including the one targeting the 5′ UTR of L1Hs [35] [36] [37] , are summarized in Supplementary Table 4 .
Genomic DNA was isolated using PureLink Genomic DNA Mini Kit (K182001, Life Technologies) with RNase A digestion to remove contaminant RNA, according to the manufacturer's instructions. Genomic DNA (300 ng per sample) was digested with 50 units PspGI (R0611S, New England Biolabs) in 1× Smart buffer (New England Biolabs) at 75 °C for 1 h, to cut uniquely at the intron of the GFP cassette. The reaction mixture was then used in qPCR experiments with primers flanking the intron in the GFP cassette (Supplementary Table 4 ). Because of the PspGI digestion, the original unspliced L1-GFP reporter will not be amplified by PCR. Only newly integrated GFP cassettes, in which the intron was removed during the retrotransposition process, can be PCR-amplified. qPCR runs and analysis were performed on the Light Cycler 480II machine (Roche). Northern blotting. Northern blotting was conducted as previously described 38 . In brief, 15 μ g of total RNA from K562 cells or H9 ES cells was separated on the 0.7% formaldehyde agarose gel, capillary transferred overnight in 20× saline sodium citrate to the Hybond N membrane (GE Healthcare), crosslinked with a Stratalinker (Stratagene), and hybridized with 32 P-labelled single-stranded DNA probes (10 6 counts per min per ml) in ULTRAhyb-Oligo Hybridization Buffer (AM8663, Life Technologies) following the manufacturer's instructions. Blots were washed twice with wash buffer (2× saline sodium citrate, 0.5% SDS), and then exposed to film overnight for several days at − 80 °C with an intensifying screen. The sequence of oligonucleotide probes is listed in Supplementary Table 3 . Single-molecule fluorescent in situ hybridization. SmFISH assays were performed following the affymetrix Quantigene ViewRNA ISH Cell Assay user manual. Between 2.5 and 5 million live K562 cells were fixed within 4% formaldehyde in 1× PBS for 60 min at room temperature, resuspended in 1× PBS, pipetted onto poly-l-lysine coated glass cover slips (around 20,000 total cells per spot; spread out with a pipette tip), and kept in a dry oven at 50 ± 1 °C for 30 min to fix the cells onto the glass slip, followed by digestion with Protease QS (1:4,000) in 1× PBS for 10 min at room temperature. Cells were hybridized with smFISH probes, designed to target β -actin mRNA (fluorescein isothiocyanate channel) and the L1-GFP reporter mRNA (Cy3 channel), stained for 5 min with 4′ ,6-diamidino-2phenylindole (DAPI), and mounted with Prolong Gold Antifade Reagent (10 ml per sample). Images were taken using a spinning disk confocal microscope equipped with 60× 1.27-numerical aperture water immersion objective with an effective pixel size of 108 × 108 nm. Specifically, for each field of view, a z-series of 8 μ m is taken with 0.5 μ m per z-step for all three channels. For quantification, maximumprojected images from the z-series is used and analysed by a custom-written MATLAB script. In brief, all images are first subtracted with the background determined with the Otsu method 39 from the log-transformed image after pillbox blurring with a radius of 3 pixels. mRNA puncta are segmented by top-hat filter using the background subtracted images and only the ones above the 25th percentile intensity of all segmented puncta are taken for downstream analysis. Each punctum is then assigned to the nuclear mask identified by image areas above the previously determined background. For each single cell, the assigned pixel area of L1-GFP mRNA is then normalized to the assigned pixel area of β -actin mRNA per cell. RNA-seq. Two independent biological replicates of K562 cells in culture were extracted to isolate a DNA-free total RNA sample, using the RNeasy kit (74104, Qiagen) combined with the RNase-free DNase Set (79254, Qiagen). PolyAselected RNA were isolated using 'Dynabeads mRNA Purification Kit for mRNA Purification from Total RNA preps' (610-06, Life Technologies) following the manuals. PolyA-selected RNA (100 ng) was fragmented with NEBNext Magnesium RNA Fragmentation Module (E6150S, New England Biolabs), and used for first strand cDNA synthesis with SuperScriptII (18064-014, Invitrogen) and random hexamers, followed by second strand cDNA synthesis with RNaseH (18021-014, Invitrogen) and DNA Pol I (18010-025, Invitrogen). The cDNA was purified, quantified, multiplexed and sequenced with 2× 75-bp pair-end reads on an Illumina NEXT-seq (Stanford Functional Genomics Facility).
RNA-seq reads were aligned to the hg38 reference genome with hisat2 (-no-mixed,-no-discordant) without constraining to known transcriptome. Known (gencode 25) and de novo transcript coverages were quantified with featureCount. Repeat Masker coverage was quantified with bedtools coverage. Reads mapping to the same repeat family were then tabulated together, because individual read coverage was too low to obtain meaningful results. Differential expression analysis of join gene-repeat data was performed with DESeq2 40 . ChIP-seq. Two replicates of ChIP experiments per sample were performed as previously described 41, 42 . Approximately 0.5-1 × 10 7 cells in culture per sample were crosslinked with 1% paraformaldehyde for 10 min at room temperature, and quenched by 0.125 M glycine for 10 min at room temperature. Chromatin was sonicated to an average size of 0.2-0.7 kb using a Covaris (E220 evolution). Sonicated chromatin was incubated with 5-10 μ g antibody bound to 100 μ l protein G Dynabeads (Invitrogen) and incubated overnight at 4 °C, with 5% kept as input DNA. Chromatin was eluted from Dynabeads after washing five times (50 mM HEPES, 500 mM LiCl, 1 mM EDTA, 1% NP-40, 0.7% sodium deoxycholate), and incubated in a 65 °C water bath overnight (12-16 h) to reverse crosslinks. ChIP DNA were subject to end repair, A-tailing, adaptor ligation and cleavage with USER enzyme, followed by size selection to 250-500 bp and amplification with NEBNext sequencing primers. Libraries were purified, quantified, multiplexed (with NEBNext Multiplex Oligos for Illumina kit, E7335S) and sequenced with 2× 75-bp pair-end reads on an Illumina NEXT-seq (Stanford Functional Genomics Facility).
ChIP-seq reads were trimmed with cutadapt (− m 50 − q 10) and aligned with bowtie2 (version 2.2.9, − no-mixed -no-discordant − end-to-end − maxins 500) to the hg38 reference genome. ChIP peaks were called with macs2 (version 2.1.1.20160309) callpeak function with broad peak option and human genome effective size using reads form corresponding to loss of gene lines as background model. Visualization tracks were generated with bedtools genomecov (− bg − scale) with scaling factor being 10 6 per number aligned reads and converted to bigWig with bedGraphToBigWig (Kent tools). BigWigs were plotted with IGV browser. Individual alignments were inspected with the IGB browser.
Heat maps were generated by intersecting bam alignment files with intervals of interest (bedtools v2.25.0), followed by tabulation of the distances of the reads relative to the centre of the interval and scaling to account for total aligned read numbers (10 6 per number aligned). Heat maps were plotted using a custom R function. Aggregate plots were generated by averaging rows of the heat map matrix. For ChIPs in control and knockout K562 clones, ChIP-seq signals in the corresponding knockout cells were used as the null reference.
For ChIP-seq repetitive sequence relationship analysis, repeat masker was intersected with ChIP-seq peak calls to classify each masker entry as MPP8-bound, MORC2-bound or unbound. Enriched families of repeats were identified with R fisher.test() followed by FDR correction with qvalue(). The distribution of sizes of occupied versus non-occupied L1 was plotted using R density() with sizes being taken from repeat masker. ks.test() was used to reject the null hypothesis that the distribution of sizes for bound and unbound L1s is the same. To investigate the relationship between L1 age, length and occupancy, logistic regression was performed with R glm() engine.
Quantitative analysis of H3K9me3 changes was performed by first identifying regions of significant enrichment in each sample relative to corresponding input sample (macs2 callpeak), merging the intervals into a common superset. This superset was joined with a decoy randomized set of intervals, twice the size of the actual experimental interval set, with the same size distribution (bedtools shuffle). Next the read coverage was determined for each sample (bedtools coverage) and regions with significant change together with fold changes were identified using DESeq2 40 . H3K9me3 regions were classified into bound or unbound by performing intersect with MORC2 and MPP8 ChIP peak calls. Data availability. All sequencing data generated in this work has been deposited in the Gene Expression Omnibus (GEO) under the accession number GSE95374. H3K4me3 and H3K27ac K562 ChIP-seq datasets in Fig. 3e are from BioProject (accession number PRJEB8620). hES-cell RNA-seq datasets in Extended Data Fig. 8c are from Sequence Read Archive (SRA) run entries SRR2043329 and SRR2043330. The complete results of genome-wide screens in K562 and HeLa cells are in Supplementary Table 1 ; the complete results of secondary screens in K562 and HeLa cells are in Supplementary Table 2 . The sequences of guide RNAs and oligonucleotides used in this work are listed in Supplementary Table 3 and Supplementary Table 4 . The uncropped scans with size marker indications are shown in the Supplementary Figure. assay on genomic DNA using primers that flank the engineered intron within the G418 R cassette. Two experiments repeated independently with similar results. The spliced PCR bands were not observed before dox induction in either K562 or HeLa cells, suggesting that the L1-G418 R reporter was not activated before the screening. However, there may exist an extremely low level of reporter leakiness that is below the detection limits of the PCR assay. c. Fluorescence-activated cell sorting experiments show that the L1-GFP cells have no GFP signals without dox induction (0 out of approximately 300,000 cells), and begin to produce GFP after dox induction. Therefore, the level of reporter leakiness without dox induction is insignificant. Two experiments repeated independently with similar results. d. CasTLE analysis of genome-wide screens in K562 cells, with 20,488 genes represented as individual points. Genes falling under 10% FDR coloured in blue, analysed by CasTLE likelihood ratio test 11 . n = 2 biologically independent screens. e. HeLa cells with L1-G418 R are resistant to G418 after dox induction (seven days of dox induction followed by ten days of G418 selection). Live cells in equal volumes were counted in a single (n = 1) fluorescence-activated cell sorting experiment. The centre value indicates the total number of live cells. Error bar, square root of total events assuming Poisson distribution of counts. . The K562 secondary screen recovers more sgRNAs than the K562 genome-wide screen, suggesting a higher detection sensitivity in the secondary screen. c, Comparison of the secondary screen data (252 genes from n = 2 independent screens) with the genome-wide screen data (n = 2 independent screens) in K562 cells. ERCC6  XRCC1  ERCC5  ERCC4  ERCC1  PARP1  POLB  APEX1  PNKP  XRCC5  XRCC6  LIG4  DCLRE1C  PRKDC  MRE11A  RAD50  NBN  FAN1  FANCM  SLX4  C17ORF70  FANCF  C19ORF40  FANCA  FANCE  UBE2T  FANCD2  FANCG  FANCL  FANCB  FANCC  FANCI  BLM  RAD52  PALB2  SWI5  RAD54L  BRCA2  RAD51B  BRCA1  XRCC2  RAD51C  RAD51D  XRCC3 
Extended Data Figure 3 | See next page for caption.
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Extended Data Figure 3 | Screen for L1 regulators in HeLa cells and and L1-sequence-dependent L1 regulators. a, CasTLE analysis of two independent genome-wide screens in HeLa cells, with 20,514 genes represented as individual points. Genes at 10% FDR cutoff coloured in red, analysed by CasTLE likelihood ratio test 11 . b, The maximum effect size (centre value) estimated by CasTLE from two independent HeLa secondary screens with ten different sgRNAs per gene. Bars, 95% credible interval. L1 activators are shown in red; L1 suppressors are shown in blue. Genes for which the credible interval includes zero are coloured in grey and are considered non-effective against L1. c, Scatter plots showing the secondary screen hits identified in K562 cells and HeLa cells (252 genes from two independent screens in each cell line), with a Venn diagram comparing hits in the two cell lines shown on the right. d, The maximum effect size (centre value) of indicated heterochromatin regulators, estimated by CasTLE from two independent HeLa secondary screens with ten different sgRNAs per gene. Error bars, 95% credible intervals of the estimated effect size. e, The maximum effect size (centre value) of indicated DNA repair genes, estimated by CasTLE from two independent HeLa secondary screens with ten different sgRNAs per gene. Error bars, 95% credible intervals of the estimated effect size. f, The (opt)-L1-GFP reporter retrotransposed more frequently than did L1-GFP in K562. The GFP + fraction of cells with the indicated L1 reporter after 15 days of dox induction was normalized to the L1-GFP sample. Box plots show median and IQR, whiskers are 1.5 × IQR. n = 6 biologically independent replicates. g, The GFP + fraction of dox-induced control and mutant cell pools with the L1-GFP reporter or (opt)-L1-GFP reporter. Experiments were performed as in Fig. 1e . Chromatin regulators (for example, TASOR, MORC2, MPP8 and SAFB) did not suppress the (opt)-L1-GFP reporter, in which 24% of the L1 ORF nucleotide sequence is altered, without changes in the encoded amino acid sequence 19, 20 , indicating that their L1 regulation depends on the native nucleotide sequence of L1Hs. h, K562 secondary screen with the (opt)-L1-G418 R reporter (252 genes from n = 2 independent screens) revealed genes that regulate retrotransposition dependent or non-dependent on the native L1 nucleotide sequence. The K562 secondary screen candidates identified with L1-G418 R (252 genes from n = 2 independent screens) are labelled in blue. A Venn diagram comparing hits identified from the two L1 reporters is shown on the top right. Extended Data Figure 4 | See next page for caption.
Extended Data Figure 4 | MORC2, MPP8 and TASOR silence L1 transcription. a, Relative genomic copy number of newly integrated L1-GFP reporters in the indicated mutant K562 pools after dox induction. The PspGI-assisted qPCR assay used here was designed to selectively detect spliced GFP rather than the unspliced version (see Methods). The L1-GFP copies were normalized to β -actin DNAs; data were then normalized to the control. As a putative L1 activator, SLTM shows an opposite effect on the DNA copy number compared with L1 suppressors. Centre value is the median; n = 3 technical replicates per gene. b, RNA-seq data in control K562 cells show that most heterochromatin regulators in Fig. 2a are expressed, supporting the selective effect of HUSH and MORC2 in L1 regulation. c, Western blots validating the effects of knockout in independent knockout K562 cell clones. Control samples were loaded at four different amounts (200%, 100%, 50% and 25% of knockout clones). Three experiments, repeated independently with similar results. To obtain knockout clones, we sorted pools of mutant K562 cells (those used in Fig. 1e, f) into 96-well plates, expanded the cells and screened for knockout clones through western blotting. Of note is that all K562 knockout clones were derived from the same starting L1-GFP reporter line, and therefore do not differ in reporter transgene integrations among the clones. d, Representative images of smFISH assays targeting ACTB mRNAs and RNA transcripts from L1-GFP reporters in control and knockout K562 clones after five days of dox induction. No signal was observed from L1-GFP reporters without dox induction (data not shown). Two experiments repeated independently with similar results. See also e and Fig. 2b (showing L1-GFP mRNA only). e, Quantification of the L1-GFP transcription level from the indicated number of K562 cells, determined by smFISH assays (d and Fig. 2b ). The number of L1-GFP mRNA transcripts is normalized to the number of β -actin mRNAs within each K562 cell. Box plots show median and IQR, whiskers are 1.5 × IQR. P value, two-sided Wilcoxon test. 95% credible interval for median from 1,000× bootstrap: control: 0.059-0.082; MORC2: 0.106-0.123; MPP8: 0.264-0.410; TASOR: 0.514-0.671. f, MORC2, MPP8 and TASOR knockouts increase the genomic copy number of newly integrated L1-GFP reporters. PspGI-assisted qPCR assays were performed as in a, but using clonal knockout K562 clones instead of mutant cell pools. Data are normalized to the control. n = 3 technical replicates; centre value is median. g, MORC2 knockout, MPP8 knockout, and TASOR knockout increase the expression of endogenous L1s. RT-qPCR experiments were performed as in Fig. 1f , but using clonal knockout K562 clones instead of mutant cell pools. n = 2 biological replicates × 3 technical replicates; centre value as median. The primers do not target the L1-GFP reporter and the cell lines were not dox-induced, so these RT-qPCR assays will not detect L1-GFP transcripts. h, Western blots showing the effects of depletion of MORC2, MPP8 and TASOR in the mutant pools of K562 cells (left) and in the mutant pools of H9 hES cells without transgenic L1 reporters (right), independently repeated twice with similar results. i, Northern blots showing increased transcription from the L1-GFP reporter in knockout K562 clones (same cell lines as in c) after five days of dox induction, independently repeated twice with similar results. As observed in Fig. 2b , whereas HUSH knockout significantly increases L1-GFP transcription, MORC2 knockout leads to only a modest increase. This is probably because the L1-GFP reporter does not contain the native L1 5′ UTR sequence, to which MORC2 binds strongly (see Extended Data Fig. 6f, g) . The 5-kb and 1.9-kb marks on the membrane refer to the 28S rRNA and 18S rRNA bands, respectively. j, Northern blots showing that disruption of MORC2, MPP8 and TASOR increases the expression level of endogenous L1Hs in hES cells, using the same cell lines as in h. Size marker indicated as in i. Independently repeated twice with similar results. k, Western blots showing protein abundance of L1_ORF1p and HSP90 in the mutant pools of K562 cells and hES cells (same cell line as shown in h), independently repeated twice with similar results. Experiments were performed without dox induction of the transgenic L1 reporter. Owing to the strong signal of bands from the knockout samples, the blots were exposed for a very short time and the band signals in the control samples were relatively very weak compared to the knockout samples; this is was also the case in i, j. Letter reSeArCH Corresponding author(s): Joanna Wysocka and Michael Bassik
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Experimental design 1. Sample size
Describe how sample size was determined. For the screen, two independent replicate screens were performed, which are sufficient for screening technologies. See Methods section, 'Genome-wide screen in K562 cells', 'Secondary screen in K562 cells' and 'Genome-wide screen and secondary screen in HeLa cells'.
Data exclusions
Describe any data exclusions.
No data was excluded.
Replication
Describe whether the experimental findings were reliably reproduced.
Once experiments and procedures were fully optimized, all attempts at replication were successful.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
K562 KO clones were allocated into experimental groups based on their genotype (Extended Data Figure 4c ). For smFISH experiments, individual cells were allocated into experimental groups based on their genotype (Figure 2b and Extended Data Figure 4d ).
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Blinding was performed during the smFISH data analyses (Extended Data Figure  4e) , where B.G. who analyzed smFISH images was blinded to all conditions. Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
determined for each sample (bedtools coverage) and regions with significant change together with fold changes were identified using DESeq2 analysis paradigm. H3K9me3 regions were classified into bound vs unbound by performing intersect with MORC2 and MPP8 ChIP peak calls. 10 . Describe the software used to collect and analyze the ChIP-seq data.
For ChIP-seq, we used standard and available softwares: Bowtie, MACS2, Bedtools. Details are provided in the Methods sections. All sequencing samples reported have been deposited at GEO under the accession number: GSE95374. Detailed Data and further code information are available on request from the authors.
